Fulcrum Therapeutics to Present at the 11th Annual Future of Genomic Medicine Conference

February 28, 2018

San Diego, Calif., March 2, 2018 – Fulcrum Therapeutics, a company focused on discovering and developing small molecule therapies that unlock gene regulation to treat serious genetic diseases, will present at the 11th Annual Future of Genomic Medicine Conference in San Diego, Calif.

Robert Gould, Ph.D., Fulcrum’s President and Chief Executive Officer, will give a presentation titled “Balancing Gene Regulation in an Era of Precision Medicine” at the Scripps Institution of Oceanography on March 2nd at 3:50pm PST.

About Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company developing new medicines to deliver a new future to patients and their families by transforming gene regulation in disease. Fulcrum’s therapies are based on modulating gene regulation via control of genetic on and off switches of disease genes. Fulcrum, headquartered in Cambridge, Mass., was launched by Third Rock Ventures in 2016 and named a “Fierce 15” company later that year. For more information, please visit www.fulcrumtx.com.


Sarah Sutton
Ten Bridge Communications
[email protected]